Cross infection: Difference between revisions
imported>Robert Badgett |
imported>Robert Badgett |
||
Line 25: | Line 25: | ||
==Surveillance== | ==Surveillance== | ||
== | ==Manifestations of cross infections== | ||
Nosocomially-acquired infection often are resistant to multiple | Nosocomial infections should be suspected when a hospitalized patients develops a [[fever]]<ref name="pmid3357068">{{cite journal |author=Bor DH, Makadon HJ, Friedland G, Dasse P, Komaroff AL, Aronson MD |title=Fever in hospitalized medical patients: characteristics and significance |journal=J Gen Intern Med |volume=3 |issue=2 |pages=119–25 |year=1988 |pmid=3357068 |doi= |url= |issn=}}</ref><ref name="pmid3826121">{{cite journal |author=McGowan JE, Rose RC, Jacobs NF, Schaberg DR, Haley RW |title=Fever in hospitalized patients. With special reference to the medical service |journal=Am. J. Med. |volume=82 |issue=3 Spec No |pages=580–6 |year=1987 |month=March |pmid=3826121 |doi= |url= |issn=}}</ref> or [[leukocytosis]]<ref name="pmid12032893">{{cite journal |author=Wanahita A, Goldsmith EA, Musher DM |title=Conditions associated with leukocytosis in a tertiary care hospital, with particular attention to the role of infection caused by clostridium difficile |journal=Clin. Infect. Dis. |volume=34 |issue=12 |pages=1585–92 |year=2002 |month=June |pmid=12032893 |doi=10.1086/340536 |url=http://www.journals.uchicago.edu/cgi-bin/resolve?CID011480 |issn=}}</ref>. | ||
==Treatment== | |||
Nosocomially-acquired infection often are resistant to multiple [[antibiotic]]s. <ref name=CDC-MDR-2006>{{citation | |||
|title = Management of Multidrug-Resistant Organisms In Healthcare Settings, | |||
| year = 2006 | |||
| author = Jane D. Siegel, Emily Rhinehart, Marguerite Jackson, Linda | |||
Chiarello, the Healthcare Infection Control Practices Advisory Committee | Chiarello, the Healthcare Infection Control Practices Advisory Committee | ||
| publisher = Centers for Disease Control | |||
| url = http://www.cdc.gov/ncidod/dhqp/pdf/ar/mdroGuideline2006.pdf}}</ref>Given the ability for [[antibiotic resistance]] to transfer among organisms, less common antibiotics may be needed to treat multidrug-resistant forms. | |||
Unfortunately, some of these antibiotics may introduce | Unfortunately, some of these antibiotics may introduce problems; one such drug recommended for MRSA, [[clindamycin]], is associated with ''[[Clostridium difficile]]'' superinfection. <ref name=Gorwitz>{{citation | author = Gorwitz RJ, Jernigan DB, Powers JH, Jernigan JA, and Participants in the CDC Convened Experts’ Meeting on Management of MRSA in the Community | id = Gorwitz | title = Strategies for clinical management of MRSA in the community: Summary of an experts’ meeting convened by the Centers for Disease Control and Prevention | year = 2006 | url = http://www.cdc.gov/ncidod/dhqp/ar_mrsa_ca.html}}</ref> | ||
==References== | ==References== | ||
<references/> | <references/> |
Revision as of 08:50, 12 February 2009
In health care, a cross infection, also called a hospital infection or a nosocomial infection, is "any infection which a patient contracts in a health-care institution."[1] Important microbes are methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa and Clostridium difficile.
Examples include ventilator-associated pneumonia, surgical site infections, and infections of indwelling catheters, such as central venous catheters and urinary catheters.
Prevention
Prevention of cross infections is a priority of the U.S. Department of Health & Human Services (HHS) and address:[2][3]
- Recommendations for Appropriate Urinary Catheter Use
- Prevention of Intravascular Catheter-Associated Infections
- Prevention of Surgical Site Infections
- Prevention of Ventilator-Associated Pneumonia
Prevention of cross infections is a priority of the Institute for Healthcare Improvement (IHI).
- From the IHI 100,000 Lives Campaign[4][5]
- "Prevent Central Line Infections…by implementing a series of interdependent, scientifically grounded steps called the "Central Line Bundle"."
- "Prevent Surgical Site Infections…by reliably delivering the correct perioperative antibiotics at the proper time." Significant reduction may be achieved by procedures as simple as proper hand washing, use of clippers rather than razors to shave the site of surgery, or prompt administration of antibiotics following surgery.[6][7]
- "Prevent Ventilator-AssociatedPneumonia…by implementing a series of interdependent, scientifically grounded steps including the 'Ventilator Bundle'."
- From the IHI 5 Million Lives Campaign:[8][9] [10]
- "Reduce Methicillin-Resistant Staphylococcus aureus (MRSA) infection…by reliably implementing scientifically proven infection control practices."
Some sources may be obscure Legionella spp., known to colonize building heating, ventilation and air conditioning (HVAC) systems, has caused infection from hospital equipment that traditionally has been considered resistant to bacterial growth, such as heated bedside humidifiers. [11] The replacement of heated with ultrasonic humidifiers reduced a risk of burns but increased the risk of infection; current practices include sterilizing humidifiers between patients, changing water frequently, and using sterile water.
Surveillance
Manifestations of cross infections
Nosocomial infections should be suspected when a hospitalized patients develops a fever[12][13] or leukocytosis[14].
Treatment
Nosocomially-acquired infection often are resistant to multiple antibiotics. [15]Given the ability for antibiotic resistance to transfer among organisms, less common antibiotics may be needed to treat multidrug-resistant forms.
Unfortunately, some of these antibiotics may introduce problems; one such drug recommended for MRSA, clindamycin, is associated with Clostridium difficile superinfection. [16]
References
- ↑ Anonymous (2024), Cross infection (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ Anonymous (2009). HHS Action Plan to Prevent Healthcare-Associated Infections: Executive Summary. U.S. Department of Health & Human Services. Retrieved on 2009-01-07.
- ↑ Anonymous (2009). HHS Action Plan to Prevent Healthcare-Associated Infections: Prevention – Prioritized Recommendations. U.S. Department of Health & Human Services. Retrieved on 2009-01-07.
- ↑ Berwick DM, Calkins DR, McCannon CJ, Hackbarth AD (2006). "The 100,000 lives campaign: setting a goal and a deadline for improving health care quality". JAMA 295 (3): 324–7. DOI:10.1001/jama.295.3.324. PMID 16418469. Research Blogging.
- ↑ Institute for Healthcare Improvement: Overview of the 100,000 Lives Campaign. Retrieved on 2008-01-03.
- ↑ “Status Quon’t”, IHI’s 2007 Progress Report (PDF file)
- ↑ "Nosocomial Infection: Approach to Postoperative Symptoms of Infection", From ACS Surgery Online, Posted 06/07/2006, E. Patchen Dellinger, M.D., F.A.C.S.
- ↑ Institute for Healthcare Improvement: Campaign. Retrieved on 2008-01-03.
- ↑ "Overview of the 5 Million Lives Campaign"
- ↑ "IHI Launches National Initiative to Reduce Medical Harm in U.S. Hospitals, Builds on 100,000 Lives Campaign" Infection Control Today, December 12, 2006
- ↑ Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (March 26, 2004), "Guidelines for Preventing Health-Care--Associated Pneumonia, 2003", Morbidity and Mortality Weekly Report 53(RR03): 1-36
- ↑ Bor DH, Makadon HJ, Friedland G, Dasse P, Komaroff AL, Aronson MD (1988). "Fever in hospitalized medical patients: characteristics and significance". J Gen Intern Med 3 (2): 119–25. PMID 3357068. [e]
- ↑ McGowan JE, Rose RC, Jacobs NF, Schaberg DR, Haley RW (March 1987). "Fever in hospitalized patients. With special reference to the medical service". Am. J. Med. 82 (3 Spec No): 580–6. PMID 3826121. [e]
- ↑ Wanahita A, Goldsmith EA, Musher DM (June 2002). "Conditions associated with leukocytosis in a tertiary care hospital, with particular attention to the role of infection caused by clostridium difficile". Clin. Infect. Dis. 34 (12): 1585–92. DOI:10.1086/340536. PMID 12032893. Research Blogging.
- ↑ Jane D. Siegel, Emily Rhinehart, Marguerite Jackson, Linda Chiarello, the Healthcare Infection Control Practices Advisory Committee (2006), Management of Multidrug-Resistant Organisms In Healthcare Settings,, Centers for Disease Control
- ↑ Gorwitz RJ, Jernigan DB, Powers JH, Jernigan JA, and Participants in the CDC Convened Experts’ Meeting on Management of MRSA in the Community (2006), Strategies for clinical management of MRSA in the community: Summary of an experts’ meeting convened by the Centers for Disease Control and Prevention, Gorwitz